Patient characteristics among R2 randomization arms
| . | Ambulatory arm . | Intensive arm . | P value . |
|---|---|---|---|
| No. patients | 82 | 82 | NA |
| RI arm* | 37/45 | 42/40 | .53 |
| Median age, y | 71 | 72 | .48 |
| AML type, no. patients | |||
| de novo AML | 72 | 73 | .99 |
| post-MDS AML | 10 | 9 | .99 |
| Median WBC count, × 109/L | 5.5 | 6.1 | .81 |
| Karyotype, no. patients | |||
| Not done | 7 | 4 | .53 |
| Failure | 7 | 9 | .79 |
| Standard-risk | 63 | 66 | .70 |
| High-risk | 5 | 3 | .72 |
| . | Ambulatory arm . | Intensive arm . | P value . |
|---|---|---|---|
| No. patients | 82 | 82 | NA |
| RI arm* | 37/45 | 42/40 | .53 |
| Median age, y | 71 | 72 | .48 |
| AML type, no. patients | |||
| de novo AML | 72 | 73 | .99 |
| post-MDS AML | 10 | 9 | .99 |
| Median WBC count, × 109/L | 5.5 | 6.1 | .81 |
| Karyotype, no. patients | |||
| Not done | 7 | 4 | .53 |
| Failure | 7 | 9 | .79 |
| Standard-risk | 63 | 66 | .70 |
| High-risk | 5 | 3 | .72 |
NA indicates not applicable.
DNR/IDA.